F Boulerice

436 total citations
15 papers, 405 citations indexed

About

F Boulerice is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, F Boulerice has authored 15 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in F Boulerice's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (4 papers). F Boulerice is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (4 papers). F Boulerice collaborates with scholars based in Canada and Germany. F Boulerice's co-authors include Mark A. Wainberg, Stephan Bour, Romas Geleziunas, John Hiscott, L Fitz-Gibbon, Kei Numazaki, André Dascal, Michel L. Tremblay, Anne Roulston and Mario D’Addario and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Journal of Virology.

In The Last Decade

F Boulerice

14 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Boulerice Canada	10	285	179	140	123	87	15	405
Mohammed F. Rabbi United States	10	223 0.8×	113 0.6×	200 1.4×	120 1.0×	59 0.7×	11	410
Remco van den Burg Netherlands	9	305 1.1×	261 1.5×	113 0.8×	64 0.5×	93 1.1×	13	447
Jason J. Coull United States	7	395 1.4×	373 2.1×	134 1.0×	192 1.6×	122 1.4×	9	603
N Chirmule United States	8	315 1.1×	87 0.5×	293 2.1×	102 0.8×	90 1.0×	8	443
Jean‐Marie Béchet France	6	209 0.7×	130 0.7×	177 1.3×	114 0.9×	169 1.9×	9	456
Tara G. Edmonds United States	9	393 1.4×	146 0.8×	285 2.0×	121 1.0×	109 1.3×	9	510
Susanna Trapp Germany	8	295 1.0×	119 0.7×	220 1.6×	113 0.9×	75 0.9×	10	417
Nanette L. Riggs United States	8	348 1.2×	243 1.4×	118 0.8×	93 0.8×	81 0.9×	10	452
Sekar Natesampillai United States	13	301 1.1×	164 0.9×	199 1.4×	104 0.8×	84 1.0×	22	413
Steven L. Knapp Germany	6	312 1.1×	271 1.5×	38 0.3×	130 1.1×	92 1.1×	7	445

Countries citing papers authored by F Boulerice

Since Specialization

Citations

This map shows the geographic impact of F Boulerice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Boulerice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Boulerice more than expected).

Fields of papers citing papers by F Boulerice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Boulerice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Boulerice. The network helps show where F Boulerice may publish in the future.

Co-authorship network of co-authors of F Boulerice

This figure shows the co-authorship network connecting the top 25 collaborators of F Boulerice. A scholar is included among the top collaborators of F Boulerice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Boulerice. F Boulerice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tremblay, Cécile, Benoît Trottier, Anita Rachlis, et al.. (2011). Treatment Durability, Effectiveness, and Safety with Atazanavir/Ritonavir-Based HAART Regimen in Treatment-Naïve HIV-lnfected Patients. HIV Clinical Trials. 12(3). 151–160. 2 indexed citations

Grossman, Ronald F., S. J. Landis, Gary Garber, et al.. (1999). Treatment of community-acquired pneumonia in the elderly: the role of cefepime, a fourth-generation cephalosporin. Journal of Antimicrobial Chemotherapy. 43(4). 549–554. 18 indexed citations

Martel, Joseph M., C Laroche, Daniel Roy, et al.. (1998). Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis. Clinical Drug Investigation. 15(2). 81–90. 7 indexed citations

Montaner, Julio, Anita Rachlis, R Beaulieu, et al.. (1994). Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.. PubMed. 7(9). 924–30. 6 indexed citations

Geleziunas, Romas, Eric J. Arts, F Boulerice, Hy Goldman, & Mark A. Wainberg. (1993). Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrobial Agents and Chemotherapy. 37(6). 1305–1312. 21 indexed citations

Roulston, Anne, Mario D’Addario, F Boulerice, et al.. (1992). Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells.. The Journal of Experimental Medicine. 175(3). 751–763. 43 indexed citations

Boulerice, F, Romas Geleziunas, Stephan Bour, et al.. (1992). Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1. Journal of Virology. 66(2). 1183–1187. 14 indexed citations

Geleziunas, Romas, Stephan Bour, F Boulerice, John Hiscott, & Mark A. Wainberg. (1991). Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1. AIDS. 5(1). 29–34. 36 indexed citations

Kleiman, Lawrence, et al.. (1991). Incorporation of tRNA into normal and mutant HIV-1. Biochemical and Biophysical Research Communications. 174(3). 1272–1280. 23 indexed citations

10.

Bour, Stephan, F Boulerice, & Mark A. Wainberg. (1991). Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. Journal of Virology. 65(12). 6387–6396. 66 indexed citations

11.

Boulerice, F, et al.. (1991). Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells. Journal of Virology. 65(10). 5589–5592. 11 indexed citations

12.

Boulerice, F & Mark A. Wainberg. (1990). Inhibition by AZT of HIV-1 Replication in Acutely Infected U-937 Cells. Journal of Leukocyte Biology. 47(6). 498–505. 4 indexed citations

13.

Boulerice, F, et al.. (1990). High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. Journal of Virology. 64(4). 1745–1755. 73 indexed citations

14.

Dascal, André, et al.. (1988). The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood. 72(6). 1904–1910. 5 indexed citations

15.

Dascal, André, et al.. (1988). The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood. 72(6). 1904–1910. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact